Live price temporarily unavailable.
American Well (AMWL) is a Health Care company. Latest news and coverage below.
| FY2018Dec 2018 | FY2019Dec 2019 | FY2020Dec 2020 | FY2021Dec 2021 | FY2022Dec 2022 | FY2023Dec 2023 | FY2024Dec 2024 | FY2025Dec 2025 | |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $114.0M | $148.9M | $245.3M | $252.8M | $277.2M | $259.0M | $254.4M | $249.3M |
| Growth (year over year) | — | +30.6% | +64.8% | +3.1% | +9.7% | −6.5% | −1.8% | −2.0% |
| Gross profit | $55.3M | $68.9M | $88.5M | $104.3M | $116.8M | $94.8M | $99.0M | $132.9M |
| Gross margin | 48.6% | 46.3% | 36.1% | 41.3% | 42.1% | 36.6% | 38.9% | 53.3% |
| Operating income | −$55.1M | −$94.7M | −$227.4M | −$179.1M | −$275.9M | −$692.1M | −$217.5M | −$105.3M |
| Operating margin | −48.4% | −63.6% | −92.7% | −70.9% | −99.5% | −267.2% | −85.5% | −42.2% |
| Net income | −$52.7M | −$87.2M | −$224.4M | −$176.3M | −$270.4M | −$675.2M | −$208.1M | −$95.7M |
| Net margin | −46.2% | −58.6% | −91.5% | −69.8% | −97.6% | −260.6% | −81.8% | −38.4% |
| EPS (diluted) | −$520.00 | −$848.00 | −$45.40 | −$13.80 | −$19.72 | −$47.50 | −$13.88 | −$5.96 |
| Balance sheet | ||||||||
| Cash and equivalents | $48.0M | $137.7M | $941.6M | $746.4M | $538.5M | $372.0M | $228.3M | $182.3M |
| Total assets | — | $499.9M | $1.38B | $1.45B | $1.22B | $589.7M | $436.0M | $323.8M |
| Total liabilities | — | $124.9M | $130.4M | $185.0M | $133.7M | $109.5M | $119.7M | $76.0M |
| Shareholders' equity | −$204.4M | −$307.1M | $1.22B | $1.24B | $1.06B | $464.2M | $304.8M | $235.6M |
| Cash flow | ||||||||
| Operating cash flow | −$74.0M | −$81.9M | −$112.5M | −$141.5M | −$192.3M | −$148.3M | −$127.3M | −$66.0M |
| Capital expenditure | $1.91M | $1.34M | $3.32M | $559.0K | $292.0K | $192.0K | $119.0K | $21.0K |
| Free cash flow | −$75.9M | −$83.2M | −$115.8M | −$142.1M | −$192.6M | −$148.5M | −$127.5M | −$66.0M |
| Q3 FY24Sep 2024 | Q4 FY24†Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25†Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $61.0M | $71.0M | $66.8M | $70.9M | $56.3M | $55.3M | $54.9M | $52.0M |
| Growth (year over year) | −1.4% | +0.5% | +12.3% | +12.9% | −7.8% | −22.1% | −17.9% | −26.6% |
| Gross profit | $22.7M | $34.4M | $35.3M | $39.8M | $29.5M | $28.3M | $28.0M | $27.6M |
| Gross margin | 37.2% | 48.4% | 52.8% | 56.1% | 52.4% | 51.2% | 51.0% | 53.0% |
| Operating income | −$47.4M | −$42.8M | −$30.4M | −$20.4M | −$29.3M | −$25.2M | −$17.4M | −$9.56M |
| Operating margin | −77.6% | −60.2% | −45.5% | −28.7% | −52.1% | −45.5% | −31.7% | −18.4% |
| Net income | −$43.5M | −$42.7M | −$18.7M | −$19.7M | −$32.4M | −$24.9M | −$10.9M | −$9.93M |
| Net margin | −71.2% | −60.1% | −28.0% | −27.8% | −57.5% | −45.1% | −19.8% | −19.1% |
| EPS (diluted) | −$2.87 | −$2.71 | −$1.19 | −$1.24 | −$2.00 | −$1.53 | −$0.66 | −$0.59 |
| Balance sheet | ||||||||
| Cash and equivalents | $244.6M | $228.3M | $222.4M | $219.1M | $200.9M | $182.3M | $179.2M | $195.9M |
| Total assets | $483.0M | $436.0M | $419.5M | $388.7M | $359.4M | $323.8M | $326.0M | $327.2M |
| Total liabilities | $132.9M | $119.7M | $113.7M | $94.1M | $92.1M | $76.0M | $85.8M | $92.9M |
| Shareholders' equity | $336.7M | $304.8M | $294.0M | $282.6M | $254.9M | $235.6M | $227.3M | $221.2M |
| Cash flow | ||||||||
| Operating cash flow | −$32.4M | −$13.4M | −$25.1M | −$4.72M | −$18.8M | −$17.4M | −$983.0K | $10.7M |
| Capital expenditure | $15.0K | $3.00K | $9.00K | $0 | $0 | $12.0K | $5.00K | $8.00K |
| Free cash flow | −$32.4M | −$13.4M | −$25.1M | −$4.72M | −$18.8M | −$17.4M | −$988.0K | $10.7M |
From American Well's 10-K and 10-Q filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. Net margin is our own calculation from those reported figures (net income ÷ revenue); it is left blank where revenue is zero or missing. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →
American Well Corporation, doing business as Amwell, is a telemedicine company based in Boston, Massachusetts, that connects patients with doctors over secure video. Amwell sells its platform as a subscription service to healthcare providers to put their medical professionals online and its proprietary software development kits, APIs, and system integrations enable clients to embed telehealth into existing workflows utilized by providers and patients.
Source: Wikipedia — Amwell (company)
American well chief product & tech. officer sells $109,746 in stock
American well chief product & tech. officer sells $109,746 in stock
American well chief accounting officer sells $8,489 in stock
American well chief accounting officer sells $8,489 in stock
Phyllis Gotlib, American well president, sells $86,801 in AMWL stock
Phyllis Gotlib, American well president, sells $86,801 in AMWL stock